Moolec Science (NASDAQ:MLEC – Get Free Report) is one of 673 public companies in the “Holding & other investment offices” industry, but how does it contrast to its rivals? We will compare Moolec Science to similar companies based on the strength of its analyst recommendations, valuation, institutional ownership, profitability, earnings, risk and dividends.
Analyst Recommendations
This is a summary of current ratings and target prices for Moolec Science and its rivals, as provided by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Moolec Science | 0 | 0 | 1 | 0 | 3.00 |
Moolec Science Competitors | 128 | 730 | 961 | 19 | 2.47 |
Moolec Science presently has a consensus target price of $6.00, indicating a potential upside of 581.82%. As a group, “Holding & other investment offices” companies have a potential upside of 56.60%. Given Moolec Science’s stronger consensus rating and higher possible upside, equities research analysts clearly believe Moolec Science is more favorable than its rivals.
Volatility & Risk
Institutional and Insider Ownership
0.1% of Moolec Science shares are owned by institutional investors. Comparatively, 54.3% of shares of all “Holding & other investment offices” companies are owned by institutional investors. 19.9% of Moolec Science shares are owned by company insiders. Comparatively, 26.7% of shares of all “Holding & other investment offices” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Profitability
This table compares Moolec Science and its rivals’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Moolec Science | -129.97% | -97.95% | -27.91% |
Moolec Science Competitors | -17.66% | -43.09% | -0.30% |
Earnings & Valuation
This table compares Moolec Science and its rivals revenue, earnings per share and valuation.
Gross Revenue | Net Income | Price/Earnings Ratio | |
Moolec Science | $5.62 million | -$7.31 million | -4.40 |
Moolec Science Competitors | $1.05 billion | $84.35 million | 62.54 |
Moolec Science’s rivals have higher revenue and earnings than Moolec Science. Moolec Science is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
Summary
Moolec Science rivals beat Moolec Science on 10 of the 13 factors compared.
Moolec Science Company Profile
Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.
Receive News & Ratings for Moolec Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Moolec Science and related companies with MarketBeat.com's FREE daily email newsletter.